|  | 


‘Maybe in January’: Harsh Vardhan in the first shot of Covid-19


Union Health Minister Harsh Vardhan said on Sunday that the people of the country could receive an injection of Covid-19 in January. His comments come days after the Health Ministry published a document, answering public questions about vaccination.

“Our first priority has been the safety and efficacy of the vaccines. We don’t want to commit to that. Personally, I think that maybe any week in January, we may be in a position to administer the first Covid vaccine to the people of India, ”Vardhan said according to the ANI news agency.

The Comptroller General of Medicines of India (DCGI) is examining requests from Bharat Biotech, Serum Institute of India (SII) and Pfizer to grant emergency use authorization for their Covid-19 vaccines. Last week, the Center had said that the DGCI had sought more data from these companies, but it will not affect the timing of the launch of the vaccine.

Also read: Second Authorized Covid-19 Vaccine Ships in US

The National Group of Experts on the Administration of Vaccines for Covid-19 (NEGVAC), headed by Dr. VK Paul, a member of NITI Aayog, has recommended that 10 million healthcare personnel, 20 million frontline workers and 270 million People older than 50 years or with comorbidities receive priority vaccines once they are available.

The group of high-level ministers (GoM) on Covid-19 met on Saturday, where Dr. Paul gave a presentation on three critical aspects of vaccination, as well as details of the six vaccine candidates being tested. in India.

In addition to the discussions on vaccines, the director of the National Center for Disease Control, Dr. Sujeet Singh, also provided the Government of Mexico, which met for the first time since October, data on the current infection situation in the country. .

Also read: Ministry of Health calls urgent key group meeting after new strain of Covid-19 found in UK

He presented an analysis of the pandemic in each state, noting critical parameters such as positivity rate, breakdown of rapid antigen test and RT-PCR ratio, concentration of cases in particular districts, and lethality within 48 and 72 hours of hospitalization. .

View original